Treatment of Nijmegen Breakage Syndrome with Decreased Serum Immunoglobulin Level
Clinical Scenario
This protocol covers the management of Nijmegen breakage syndrome in patients who have a decreased serum immunoglobulin level. Immunoglobulin deficiency in this setting carries defined clinical implications that require targeted intervention.
Presenting Finding
A decreased serum immunoglobulin level is the specific condition driving the management approach described here. Patients with this finding require treatment directed at correcting and maintaining adequate immunoglobulin levels.
Treatment Overview (Partial)
Immunoglobulin replacement therapy is the central intervention in this situation. The full protocol specifies the route, the quantitative target to be maintained, and the monitoring framework — none of which are reproduced here.
Complete dosing targets, monitoring thresholds, and the structured regimen are available in the full protocol below.
References
- Patients with a decreased immunoglobulins level should receive intravenous immunoglobulins (IVIG).
- According to current guidelines for immunoglobulin supplementation in primary immunodeficiencies, NBS patients should receive IVIG to maintain a serum IgG level over 5.0 g/l.
View source ↗